Sign in for the best experience.
Everything we publish is designed to keep you up-to-date on the latest news, approaches, and ideas in chest medicine. From the most relevant research findings to the most significant clinical guidelines, these are the highly accredited resources you count on from CHEST.
Advertisement
Used throughout the world, our multidisciplinary guidelines help translate quality evidence into applicable recommendations that enrich patient care and improve health outcomes.
FEATURED GUIDELINE
Red Blood Cell Transfusion in the ICU
This CHEST guideline contains six evidence-based recommendations for RBC transfusion among critically ill patients overall and specific subgroups, including patients with gastrointestinal bleeding, acute coronary syndrome, and more.
Acquisition and Handling of Endobronchial Ultrasound Transbronchial Needle Samples
This CHEST guideline contains nine evidence-based recommendations to identify best practices for the collection, processing, and handling of EBUS-TBNA specimens.
Access CHEST’s full collection of guidelines, expert panel reports, and consensus statements.
Guideline topics
Airway Disorders
Chest Infections
Clinical Pulmonary
Critical Care
Interstitial Lung Disease
Interventional Pulmonary
Pulmonary Vascular
Thoracic Oncology
Guide future developments in content and information dissemination for the journal CHEST®. Share your reading habits and interests in a brief survey. TAKE THE SURVEY »
The CHEST® journal portfolio features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine—pulmonary, critical care, and sleep medicine—and related disciplines. With a loyal readership base, the portfolio, including the journals CHEST, CHEST® Critical Care, and CHEST® Pulmonary, is one of the most highly regarded, and up-to-date sources of clinical knowledge in the field.
Association Between Sex and Race and Ethnicity and IV Sedation Use in Patients Receiving Invasive Ventilation
IV sedation is an important tool for managing patients receiving invasive ventilation, yet excess sedation is harmful, and dosing could be influenced by implicit bias. An article in CHEST® Critical Care investigates the associations between sex or race and ethnicity and sedation practices.
A 1-Year Weight Management Program for Difficult-to-Treat Asthma With Obesity
Obesity-associated asthma results in increased morbidity and mortality. A study in the journal CHEST® examined whether use of the Counterweight-Plus Programme could result in improved asthma control and quality of life compared with usual care at one year in patients with difficult-to-treat asthma and obesity.
See if you can answer this question based on a recent journal CHEST article.
Each month, the journal CHEST Editor in Chief Peter Mazzone, MD, MPH, FCCP, adds context and commentary to important articles featured in the new issue.
OPEN ACCESS JOURNALS | Submit your research to be published in our new journals. CHEST® CRITICAL CARE » | CHEST® PULMONARY »
Whatever your specialty, CHEST has a topic collection that you’ll be interested in. Uncover insights from key opinion leaders, find CME opportunities, and discover original research articles.
Clinical advances, practice management updates, medical conference highlights—reading the CHEST Physician® publication is the easiest way to be in the know every month.
Do you want to hear directly from your colleagues on the topics that matter most? Catch up on episodes that feature critical discussions with giants in the field and hear directly from authors featured in CHEST journal.
Originally aired: February 3, 2025
CHEST® journal Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key articles published in the February 2025 issue.
Originally aired: January 6, 2025
Nathan C. Nowalk, MD, and Babak Mokhlesi, MD, FCCP, discuss their research into the association between gender and outcomes among hospitalized and ambulatory adults with obesity hypoventilation syndrome.
Ryota Sato, MD, MPH, FCCP, discusses his research into the potential survival benefits associated with the use of ultra-short-acting β-blockers (esmolol or landiolol) in patients with sepsis with persistent tachycardia.
Originally aired: December 2, 2024
Angela O. Suen, MD, discusses her research comparing health care and palliative care use by patients with COPD, idiopathic pulmonary fibrosis, and lung cancer at the end of life.